1. Introduction {#sec1-ijerph-17-05131}
===============

Hospital-acquired infections (HAIs) are a serious healthcare problem, with about 2 million cases diagnosed every year both in the USA and the European Union \[[@B1-ijerph-17-05131],[@B2-ijerph-17-05131],[@B3-ijerph-17-05131]\]. In the USA alone, about \$28--45 billion are spent every year to treat patients with HAIs \[[@B4-ijerph-17-05131]\].

Pathogens causing HAIs can survive for weeks or months on non-disinfected surfaces, such as bed rails, medical equipment, phones, keyboards, and patients' files \[[@B5-ijerph-17-05131],[@B6-ijerph-17-05131],[@B7-ijerph-17-05131],[@B8-ijerph-17-05131],[@B9-ijerph-17-05131]\]. These pathogens are often multidrug-resistant, including methicillin-resistant *S. aureus*, carbapenem-resistant *P. aeruginosa*, vancomycin-resistant *E. faecium,* and extended-spectrum β-lactamase-resistant *K. pneumoniae* \[[@B10-ijerph-17-05131],[@B11-ijerph-17-05131]\]. It seems that using standard cleaning products and complying with prevention practices, such as proper hand hygiene, are not sufficient to stop HAIs \[[@B12-ijerph-17-05131]\]. Therefore, additional methods of decontamination are needed in hospitals.

No-touch automated disinfection (NTD) is a promising approach to reduce HAIs. NTD systems are based on vaporised hydrogen peroxide (VHP), hydrogen peroxide vapor (HPV), chlorine dioxide, gaseous ozone, dry mist of hydrogen peroxide (DMHP), or aerosolised hydrogen peroxide (aHP), often complemented with silver cations, aerosolised peracetic acid, quaternary ammonium compounds, high-intensity narrow-spectrum (405 nm) light, and pulsed-xenon UV (PX-UV) radiation \[[@B13-ijerph-17-05131],[@B14-ijerph-17-05131],[@B15-ijerph-17-05131]\]. Among the currently available systems, ultraviolet light devices PX-UV and ultraviolet light-C allow to achieve a log10 reduction in pathogen content of 2--4, aHP systems of ≤ 4, whereas a log10 reduction greater than six is reported for vapor chlorine dioxide, hydrogen peroxide-based VHP, HPV, and dual peroxone systems \[[@B16-ijerph-17-05131],[@B17-ijerph-17-05131],[@B18-ijerph-17-05131]\]. Chemical NTDs are presented in [Figure 1](#ijerph-17-05131-f001){ref-type="fig"}. From all NTD systems, technologies based on advanced oxidation processes are of particular interest. Hydrogen peroxide is a potent oxidant, demonstrating stronger biocidal activity in the form of vapor than in aerosol \[[@B15-ijerph-17-05131]\]. In advanced oxidation technologies, hydrogen peroxide is combined with ozone to create peroxone---a highly potent oxidative compound \[[@B19-ijerph-17-05131]\].

Data on the performance of peroxone-based NTD systems in hospital settings are limited. Therefore, we assessed the effectiveness of an NTD system in decontamination of critical surfaces in different hospital rooms using two methods: classical microbiological assay---demanding time to obtain results of bacteria growth---and fast ATP bioluminescence assay.

2. Material and Methods {#sec2-ijerph-17-05131}
=======================

2.1. Study Design and Sample Collection {#sec2dot1-ijerph-17-05131}
---------------------------------------

This study was conducted in an oncological hospital in Poland. Contamination of five different surfaces in 10 hospital rooms (see [Table 1](#ijerph-17-05131-t001){ref-type="table"}) was measured before and after NTD with an ATP bioluminescence assay and a microbiological assay. The samples for both assays were collected on different days in September 2019.

According to the manufacturer's instructions, before NTD, all hospital rooms were cleaned and disinfected with two types of cleaning solution: 55% ethanol + quaternary ammonium propionate---for small surfaces (holders, tables, medical equipment, etc.), and N-(3-aminopropyl)-N-dodécylopropane-1,3-diamine + dodecyl dimethyl ammonium chloride---for large surfaces (floors). The samples were collected up to 15 min after the initial cleaning.

For NTD, we used the system which sprays a peroxone vapor, a combination of hydrogen peroxide and ozone, to decontaminate all surfaces.

The duration of decontamination was one hour each time. The decontamination cycle consisted of the following phases: hydrogen peroxide phase, ozone phase---in which peroxone was formed, and one-hour contact phase. Next, the rooms were aerated for another hour.

Technical properties of NTD system used in the study were as follows:Disinfectant compound usage: 8 mL/m^3^Particle size generated by the device: 5--8 µm (dry mist)Hydrogen peroxide concentration: 7.5%Maximum ozone concentration: 3 ppmContact time---1 h.Aerating time---1 h.

NTD system user guidelines strictly prohibit human attendance during the procedure. In our study, according to the guidelines, during NTD procedure the rooms were empty. The staff was allowed to enter the rooms after 2 h, when hydrogen peroxide concentration reached levels below 1 ppm. The samples were taken immediately after the aeration (i.e., 2 h after peroxone was formed).

2.2. ATP Bioluminescence Assays {#sec2dot2-ijerph-17-05131}
-------------------------------

ATP bioluminescence assays show general organic contamination such as bacteria, food, or human secretions and excretions \[[@B20-ijerph-17-05131]\]. These assays are based on the chemiluminescence properties of a luciferin-luciferase reagent, which emits light in the presence of ATP \[[@B21-ijerph-17-05131]\]. We used 3M Clean-Trace ATP Surface Test swabs (3M Company, St. Paul, MN, USA) to sample surfaces, according to the manufacturer's recommendations. All surfaces were swabbed for 30 s, and the swabs were returned to the swab device. The ATP tests were read immediately or within 1 h of collection. The samples were analysed with a 3M Clean-Trace NGi Luminometer (3M Company, St. Paul, MN, USA), and the results were reported in relative light units (RLU). In a hospital setting, RLU \> 250 is considered as unacceptable contamination \[[@B22-ijerph-17-05131]\].

2.3. Microbiological Assay {#sec2dot3-ijerph-17-05131}
--------------------------

Due to the fact that most of the surfaces assessed in our study were not flat, we decided to use 3M™ Petrifilm™ plates (London, ON, Canada) \[[@B23-ijerph-17-05131]\]. Each plate (contact surface 20 cm^2^) contained a build-in grid to facilitate colony counting, water-soluble gelling agent, nutrients, and red dye indicator. The detailed composition of the medium was not provided by the manufacturer. In order to neutralise the disinfectants used during initial cleaning phase, each plate was hydrated with 1 cm^3^ of sterile disinfectant neutralizer: broth 1000 cm^3^, Tween 80 30.0 g, soy lecithin 3.0 g, L-histidine 1.0 g, thiosulfate 0.5 g. After the hydration, the plates were left for 1 h in room temperature and the gel was formed.

During the sample collection, the plates were pressed on each surface (500 g/cm^2^) for 10 s, with no side movements. The plates were incubated at 37 °C for 48 h under aerobic conditions. Then, the growth of micro-organisms was measured in colony-forming units (CFU) per 100 cm^2^ \[[@B24-ijerph-17-05131]\]. Values \>100 CFU/100 cm^2^ were regarded as unacceptable contamination.

2.4. Statistical Analysis {#sec2dot4-ijerph-17-05131}
-------------------------

Values from the two assays were presented for all surfaces before and after NTD. We used the following cut-offs for unaccepted contamination: ≥250 RLU in the ATP assay, and \>100 CFU/100 cm^2^ in the microbiological assay. The McNemar test with continuity correction was used to assess whether NTD decreased the number of surfaces with unacceptable contamination significantly. The Wilcoxon test was used to compare the differences in median contamination before and after NTD. *p* \< 0.05 was considered significant. R software (version 3.52, R Foundation for Statistical Computing, Vienna, Austria) was used for all calculations.

3. Results {#sec3-ijerph-17-05131}
==========

In total, 50 surfaces from 10 rooms were tested. The results are presented in [Figure 2](#ijerph-17-05131-f002){ref-type="fig"} and [Table 1](#ijerph-17-05131-t001){ref-type="table"}, in which unacceptable contamination is shown in bold.

3.1. Microbiological Assay {#sec3dot1-ijerph-17-05131}
--------------------------

Before NTD, unacceptable contamination was detected on 11 of 50 surfaces. Contamination was acceptable on all tested surfaces in the Patient Recovery Room 2, Operating Room 1, and Ward no. 116. The greatest contamination (1150 CFU/100 cm^2^) was detected on a treatment lamp holder. After NTD, contamination was acceptable on all surfaces in all rooms. The greatest contamination (70 CFU/100 cm^2^) was detected on the phone in the patient recovery room. NTD decreased significantly the number of surfaces with unacceptable contamination measured with the microbiological assay: from 11/50 to 0/50 (*p* \< 0.001). Similarly, the reduction in median contamination on all surfaces was also significant (*p* \< 0.001, [Figure 2](#ijerph-17-05131-f002){ref-type="fig"}A)

3.2. ATP Bioluminescence Assay {#sec3dot2-ijerph-17-05131}
------------------------------

Before NTD, unacceptable contamination was detected on 28 of 50 surfaces. None of the rooms had acceptable contamination on all surfaces. The greatest contamination was detected on the phone in Operating Room 4 (2331 RLU), the phone in the Patient Recovery Room 1 (2552 RLU), and the Ambu bag in the Patient Recovery Room 1 (10,874 RLU). After NTD, acceptable contamination on all surfaces was detected in the Endoscopy Unit, Ward no. 116, and in the Patient Recovery Room 2. The greatest contamination was detected on the phone (1178 RLU), bed railing (1119 RLU), and Ambu bag in the Patient Recovery Room 1 (7123 RLU). NTD decreased, non-significantly, the frequency of surfaces with unacceptable contamination measured with the ATP bioluminescence assay: from 28/50 to 13/50 (*p* = 0.176). However, the reduction in median contamination on all surfaces was significant (*p* \< 0.001, [Figure 2](#ijerph-17-05131-f002){ref-type="fig"}B).

4. Discussion {#sec4-ijerph-17-05131}
=============

The NTD system used in this study reduced microbiological contamination in different hospital rooms. NTD decreased significantly the number of surfaces with unacceptable contamination measured with the microbiological assay, but not with the ATP bioluminescence assay.

The efficiency of decontamination depended on the given surface. On some surfaces, contamination measured with the ATP assay decreased only slightly after NTD---for example, on an operating lamp holder (379 vs. 371 RLU) or X-ray apparatus keyboard (854 vs. 751 RLU). On other surfaces, such as a remote control, contamination decreased considerably (495 vs. 25 RLU). Such differences may be associated with the type of material of the decontaminated surface. In the study by Eschlbeck et al. \[[@B25-ijerph-17-05131]\], it was observed that the rate of decontamination with hydrogen peroxide depended on the hydrophobicity of the material, while its porosity played a minor role. Also, the amount of the agent used in NTD may influence the effectiveness of the process, as shown in the study by Horn and Niemeyer \[[@B26-ijerph-17-05131]\], in which better outcomes were achieved by increasing the volume of peracetic acid.

In our study, the number of surfaces with unacceptable microbiological contamination before NTD was much higher when assessed with the ATP bioluminescence assay than the microbiological assay (28 vs. 11 surfaces). The greatest contamination measured with the microbiological assay exceeded the acceptable level by more than 11-fold (treatment lamp holder, 1150 CFU/100 cm^2^), and, for the ATP bioluminescence assay, by more than 43-fold (Ambu bag, 10,874 RLU). After decontamination with the NTD system, the number of surfaces with unacceptable contamination was still much higher when measured with the ATP bioluminescence assay than with the microbiological assay (13 vs. 0).

Several studies have compared ATP bioluminescence and microbiological assays. In a study evaluating over 80 different surfaces, a microbiological assay showed unacceptable contamination on about 20% of surfaces before cleaning, and on about 6% after cleaning; the respective figures for an ATP assay were considerably higher: 50% and 20%, respectively \[[@B27-ijerph-17-05131]\]. In another study assessing the effects of decontamination with vaporised hydrogen peroxide, a standard microbiological assay, but not an ATP bioluminescence assay, showed multiple log-reductions in contamination \[[@B28-ijerph-17-05131]\]. Those investigators concluded that the ATP bioluminescence assay should not be an alternative to standard microbiological methods \[[@B28-ijerph-17-05131]\]. Our study is in line with these findings. Indeed, in a review by Nante et al. \[[@B29-ijerph-17-05131]\], from 14 papers assessing correlation between RLU and aerobic colony counts (ACC), three of the studies showed no correlation, and four of them showed only poor/moderate correlation. However, because different ATP assays with no standardised threshold are available, comparisons between studies are challenging. Of note, a new standard EN 17272:2020 was approved by the Technical Committee 216 of European Committee for Standardisation (CEN/TC 216), describing the methods to determine the disinfectant activity of automated processes for distributing chemicals by air diffusion \[[@B30-ijerph-17-05131]\]. The unified standard will provide guidance for future research, making future studies more comparable.

ATP assays are not optimal for estimating of the risk of infection. These assays cannot distinguish between pathogenic and non-pathogenic bacteria and between live and dead cells. The relationship between the level of residual surface contamination and the risk of infection after conventional disinfection has not been extensively studied. However, multiple studies revealed that subsequent patients occupying the hospital room after infected individuals are at increased risk of infection \[[@B31-ijerph-17-05131],[@B32-ijerph-17-05131],[@B33-ijerph-17-05131],[@B34-ijerph-17-05131],[@B35-ijerph-17-05131]\]. Probably the conventional methods do not sufficiently prevent from disease transmission. Bshabshe et al. \[[@B36-ijerph-17-05131]\] showed that NTD can reduce that risk. In another study, Anesi et al. \[[@B37-ijerph-17-05131]\] observed a reduction in *Clostridioides (Clostridium) difficile* rate from 1.73 to 0.93 cases per 1000 patient-days in the 12 months after NTD implementation. Being especially valuable in heavy patient overload, when the risk of disease transmission is high, NTD systems have been recommended in SARS-CoV-2 pandemic management \[[@B38-ijerph-17-05131]\].

In assessing the effectiveness of cleaning and decontamination methods, particular consideration should be paid to potential human errors, e.g., improper formulation or contact time of the agent, sensitive area omission, etc. \[[@B39-ijerph-17-05131]\]. NTD systems eliminate the impact of the human factor. Our study is in line with other trials \[[@B40-ijerph-17-05131]\] confirming that NTD can effectively inactivate pathogenic microorganisms while conventional methods remain insufficient.

The limitations of our study need to be mentioned. First, the sample size, i.e., the number of surfaces and hospital rooms that were evaluated was small. Second, the chemical compounds used in our study before NTD can interfere with ATP-based assays \[[@B41-ijerph-17-05131]\]. Also, we did not identify the species present in the examined rooms before and after using NTD system. Qualitative methods of assessment would be particularly valuable in assessing the risk of HAI before and after decontamination, however, quantitative methods seem to support the effectiveness of NTD system as it reduced the contamination levels below standards commonly used in clinical settings.

Finally, in microbiological tests, we used the value \>100 CFU/100 cm^2^ as a threshold of unacceptable contamination, which is not common in other research. Some authors suggest for clinical surface hygiene assessments the same threshold as for the food industry (\>250 CFU/100 cm^2^) \[[@B42-ijerph-17-05131]\]. This standard has been implemented in many studies \[[@B43-ijerph-17-05131],[@B44-ijerph-17-05131],[@B45-ijerph-17-05131],[@B46-ijerph-17-05131]\]; however, it is not clear if it is adequate for the prevention of disease transmission in healthcare facilities \[[@B47-ijerph-17-05131]\]. Hence, we decided to use a stricter standard \[[@B24-ijerph-17-05131]\]. According to Carling et al. \[[@B48-ijerph-17-05131]\], only surfaces with undetectable levels of biological contamination (0 CFU) achieved after documented cleaning can be considered successfully decontaminated.

5. Conclusions {#sec5-ijerph-17-05131}
==============

In summary, our study showed that NTD is a feasible method of decontamination: when added to standard decontamination procedures, it can further decrease the risk of HAIs. It seems that ATP bioluminescence assays with standard cut-off are not valid for assessing the effectiveness of NTD. Further studies are needed to standardise the cut-off values.
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###### 

Surface contamination before and after no-touch disinfection in different hospital rooms.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                          Microbiological Assay\   ATP Bioluminescence Assay\                
                                                                                          (CFU/100 cm^2^)          (RLU)                                     
  ------------------------------------------------ -------------------------------------- ------------------------ ---------------------------- ------------ ----------
  **Operating Room 4**                             Operating lamp holder                  15                       0                            **379**      **371**

  Upper surface of operating table                 5                                      0                        172                          85           

                                                   Anaesthetic machine (table)            45                       0                            159          78

                                                   Mayo table                             0                        0                            172          64

                                                   Phone                                  **560**                  0                            **2331**     **599**

  **Treatment Room in Ward I**                     Treatment lamp holder                  **1150**                 0                            **1119**     **508**

  Upper surface of mattress                        10                                     5                        155                          103          

                                                   Treatment table                        **150**                  0                            **840**      120

                                                   Sink                                   15                       0                            176          22

                                                   Locker holder under sink               5                        0                            **587**      87

  **Patient Recovery Room 1**                      Phone                                  **560**                  70                           **2552**     **1178**

  Bed remote control                               10                                     0                        **668**                      229          

                                                   Bed railing                            **215**                  0                            **1905**     **1119**

                                                   Ambu bag                               **400**                  10                           **10,874**   **7123**

                                                   Sink                                   10                       0                            **253**      32

  **Endoscopy Unit: automatic disinfector room**   Sink                                   0                        0                            70           24

  Locker holder                                    **400**                                0                        **356**                      64           

  Remote control of disinfector                    0                                      0                        **746**                      51           

                                                   Inside of automatic disinfector        0                        0                            144          19

                                                   Tap above sink                         10                       0                            **320**      161

  **Endoscopy Unit: examination room**             Video track endoscopy keyboard         **305**                  0                            **656**      156

  Blood pressure cuff                              40                                     0                        **1308**                     **270**      

                                                   Anaesthesiological table               90                       0                            74           57

                                                   Storage                                35                       5                            **436**      171

                                                   Anaesthesiological table handle        **725**                  20                           **488**      170

  **Operating Room 1**                             Upper surface of operating table       0                        0                            175          87

  Operating lamp holder                            0                                      0                        75                           50           

                                                   Computer mouse                         25                       15                           **1230**     **514**

                                                   X-ray apparatus keyboard               35                       15                           **854**      **751**

                                                   Ambu bag                               0                        0                            116          88

  **Operating Room 2**                             Infusion pump remote control panel     0                        0                            **918**      **450**

  Ambu bag                                         **135**                                0                        **1349**                     **437**      

                                                   Anaesthesiological table               0                        0                            148          82

                                                   Blood pressure cuff                    20                       0                            121          34

                                                   Operating table remote control panel   0                        0                            **583**      **430**

  **Ward no. 116**                                 Calling staff pilot                    1                        0                            80           50

                                                   Mattress                               20                       5                            **291**      153

                                                   Toilet flush button                    0                        0                            38           17

                                                   Bedside table                          100                      5                            235          127

                                                   Bed railing                            30                       0                            232          215

  **Patient Recovery Room 2**                      Infusion pump control panel            0                        0                            160          120

  Sink                                             0                                      0                        **286**                      80           

                                                   Bedside table                          0                        0                            **495**      118

                                                   Cardiomonitor screen                   0                        0                            **284**      250

                                                   Handle locker                          0                        0                            173          34

  **Treatment Room Ward I**                        Bed remote control                     5                        0                            **495**      25

  Sink                                             10                                     0                        36                           20           

                                                   ECG apparatus keyboard                 **150**                  15                           **1905**     **661**

                                                   Treatment lamp holder                  15                       0                            134          41

                                                   Upper surface of mattress              100                      0                            199          59
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Notes: unacceptable contamination is shown in bold.
